0 ratings
Bortezomib in the Treatment of Multiple Myeloma (Milestones in Drug Therapy) 2011th Edition
Bortezomib is a promising anticancer drug targeting the proteasome.
Bortezomib in the Treatment of Multiple Myeloma (Milestones in Drug Therapy) 2011th Edition
Item #: 19018753

Bortezomib in the Treatment of Multiple Myeloma (Milestones in Drug Therapy) 2011th Edition

Item #: 19018753

INR 10977

Price Details

Price

INR 10977

M.R.P. INR 10977

Excluding Shipping & Custom charges ( Shipping and custom charges will be calculated on checkout )

*All items will import from US

0 ratings Write a review
In stock
us Imported from USA store
Order now and get it around Tuesday, August 25
Our Top Logistics Partners
  • fedex
  • dhl
Bortezomib is a promising anticancer drug targeting the proteasome.
U-Care Warranty:
None
Select a Plan
fast shipping

Fast
Shipping

free return

Free
Return*

secure packaging

Secure Packaging

100% original products

100% Original Products

pci-dss

PCI DSS Compliance

iso certified

ISO 27001 Certified


paypal payment
discover payment
visa payment
diners club payment
mastercard payment
american express payment
rupay payment
Ships from Ubuy, Sold by: UBNA Distribution LLC
Note: Step Down Voltage Transformer required for using electronics products of US store (110-120). Recommended power converters Buy Now.

What Stands Out

Comprehensive Overview
This edition provides an extensive examination of Bortezomib, detailing its development, mechanism, and therapeutic impact on multiple myeloma, making it an essential resource for healthcare professionals and researchers.
Evidence-Based Insights
Incorporates cutting-edge research and clinical trials, offering evidence-based insights that enhance understanding of Bortezomib’s efficacy and its role in treatment regimens, supporting informed decision-making in patient care.
Updated Protocols
Includes the latest treatment protocols and guidelines for using Bortezomib, ensuring that practitioners have current, best-practice information for integrating this drug into modern multiple myeloma therapy.

Product Details

Discover Bortezomib, a breakthrough drug for Multiple Myeloma treatment. Order now from Ubuy India and avail global delivery. Shop now!
  • Bortezomib is a promising anticancer drug targeting the proteasome
  • Induces cell stress and apoptosis in cancer cells
  • Valuable source of information for researchers and clinicians in oncology and pharmacology
  • Useful for those working in academia or the pharmaceutical industry
  • Focuses on the treatment of Multiple Myeloma (MM) using bortezomib
  • Offers insights into the mechanisms and potential benefits of proteasome inhibition
Country of OriginThis item will be imported from US
What is in the boxBortezomib in the Treatment... For more details, please check description/product details

Who Should Buy?

Suitable For
  • Healthcare Professionals

    Oncologists and healthcare professionals seeking comprehensive information on Bortezomib and its efficacy for treating multiple myeloma.

  • Medical Students

    Students studying oncology or drug therapy will benefit from detailed insights into Bortezomib's role in treatment protocols.

  • Patients and Caregivers

    Individuals affected by multiple myeloma who want to understand treatment options and experiences with Bortezomib.

Not Suitable For
  • General Public

    Individuals not involved in healthcare may find the technical content challenging and less relevant for general health understanding.

Product Description

Bortezomib in the Treatment of Multiple Myeloma (Milestones in Drug Therapy) 2011th Edition

Have any Query? Chat with us

Customer Questions & Answers

  • Question: What is Bortezomib and how does it work in treating Multiple Myeloma?

    Answer: Bortezomib is a proteasome inhibitor used as a chemotherapy drug in the treatment of Multiple Myeloma. It works by blocking the proteasome's function, leading to the accumulation of proteins that promote apoptosis, or programmed cell death, in cancer cells. This helps to hinder the growth of malignant plasma cells. In practice, patients may experience a reduction in tumor size and improvement in blood cell counts, making Bortezomib a pivotal part of combination therapies.
  • Question: What are the side effects of Bortezomib?

    Answer: Common side effects of Bortezomib can include nausea, fatigue, nerve damage, and low blood cell counts. Understanding these potential effects allows patients and caregivers to be proactive in managing symptoms and coordinating care. For instance, if a patient experiences severe fatigue, adjustments to their daily schedule and lifestyle might be warranted to ensure they maintain a good quality of life during treatment.
  • Question: How is Bortezomib administered to patients?

    Answer: Bortezomib can be administered via injection either subcutaneously or intravenously. The route and method depend on the specific treatment plan and the doctor's guidance. Patients might find subcutaneous injections more convenient as they can be less painful and simpler, helping to enhance compliance and ensuring the effectiveness of the therapy.
  • Question: What is the significance of the 2011 edition in drug therapy milestones for Bortezomib?

    Answer: The 2011 edition highlights pivotal studies and advancements in the use of Bortezomib over the years. It showcases critical milestones, including its approval and combination with other therapies, which have shaped current treatment protocols. This edition serves not just as a historical reference but also provides insights for clinicians in optimizing treatment strategies for more effective outcomes.
  • Question: Can Bortezomib be used in combination with other treatments?

    Answer: Yes, Bortezomib is often used in combination with other drugs such as dexamethasone and lenalidomide to enhance its effectiveness. This multi-drug approach is crucial as it attacks cancer cells from various angles, potentially leading to better remission rates. Combining therapies allows for more tailored treatment plans based on individual responses, expanding options for patients facing Multiple Myeloma.
  • Question: What should I know about monitoring while on Bortezomib therapy?

    Answer: Monitoring is essential during Bortezomib therapy due to its effects on blood counts and nerve health. Regular blood tests will help track changes and guide necessary adjustments in treatment. Additionally, patients should be vigilant for any new or worsening symptoms, enabling prompt medical response and management which is crucial for ensuring safe and effective treatment.
  • Question: What lifestyle changes may support patients undergoing Bortezomib treatment?

    Answer: Patients are encouraged to maintain a balanced diet, stay hydrated, and engage in light physical activity as tolerated, all of which contribute to overall health during treatment. Stress management practices such as mindfulness and yoga can also be beneficial. These lifestyle choices help bolster the body’s response to treatment and enhance the overall well-being of individuals fighting Multiple Myeloma.
  • Question: Is there a specific diet recommended for patients on Bortezomib?

    Answer: While there isn't a one-size-fits-all diet, a balanced intake rich in fruits, vegetables, lean proteins, and whole grains is generally recommended. Adequate nutrition can support immune function and help manage side effects such as nausea. For instance, consuming small, frequent meals can alleviate gastrointestinal discomfort, making it a practical strategy for those undergoing therapy.
  • Question: Are there any support resources for patients receiving Bortezomib?

    Answer: Several organizations provide support for patients undergoing Multiple Myeloma treatment with resources such as educational materials, counseling, and community support groups. Connecting with such resources can offer emotional support and useful information, aiding patients in navigating their journey through treatment more effectively.
  • Question: Where can I buy Bortezomib in the Treatment of Multiple Myeloma Milestones in Drug Therapy 2011th Edition?

    Answer: You can purchase the 2011th Edition of Bortezomib in the Treatment of Multiple Myeloma Milestones in Drug Therapy through Ubuy. Ubuy offers a user-friendly platform where you can find this specific edition, ensuring that you receive a reliable source for your medical literature needs, ultimately aiding in informed decisions about treatment.

Cell Biology Editorial Review

No editorial reviews found

Customer Reviews & Ratings

5.0
1 customers ratings
  • 5 Star
    100%
  • 4 Star
    0%
  • 3 Star
    0%
  • 2 Star
    0%
  • 1 Star
    0%

Review this product

Share your thoughts with other customers

Pros

  • Effective treatment option
  • Improves patient outcomes
  • Wide range of research support
  • Well-tolerated by many patients
  • Comprehensive information provided

Cons

  • Some may experience mild side effects.

Platform Trust & Buyer Confidence

trustpilot logo
4.1/5 1557 reviews
Read reviews
PC
Paritosh
Verified buyer

“Quality, fit, and variety are all good. Very good quality, perfect fit, with a good variety in 70s Bellbottom jeans. Keep them coming.”

20-Jul-26 · via Trustpilot
AV
Aggarwal
Verified buyer

“Everything was well maintained and smooth . We can trust UBUY .”

23 July 2026 · via Trustpilot
JM
Jeeju
Verified buyer

“Product is nice. Well packaged and delivered promptly”

23 July 2026 · via Trustpilot
NG
neeraj
Verified buyer

“Product was delivered before time. At each steps remider given time to time ,product is also good and fruitful”

3 July 2026 · via Trustpilot
SP
siva
Verified buyer

“I received the product properly packed and without any damage. If you can provide a video showing how to assemble the parts, it would be a great help. Thanks & Regards, Siva Prakash.”

16-Jul-26 · via Trustpilot
Secure Checkout Global Delivery Easy Returns Genuine Products

Product Price History

Important information

  • Limitations : For products shipped internationally, please note that any manufacturer warranty may not be valid; manufacturer service options may not be available; product manuals, instructions, and safety warnings may not be in destination country languages; the products (and accompanying materials) may not be designed in accordance with destination country standards, specifications, and labeling requirements; and the products may not conform to destination country voltage and other electrical standards (requiring use of an adapter or converter if appropriate). The recipient is responsible for assuring that the product can be lawfully imported to the destination country. When ordering from Ubuy or its affiliates, the recipient is the importer of record and must comply with all laws and regulations of the destination country.
  • Not all the products listed on Ubuy are for sale, as Ubuy is a global search engine. Products are subject to export/trade regulations.